Emerald Health Therapeutics Inc. announced the appointment of Robert C. Hill, CPA, CA, as the company's Chief Financial Officer and the promotion of Cheryl L. Evans, CPA, CA, to Vice President Finance. Together Mr. Hill and Ms. Evans will be responsible for leading Emerald's financial operations and organizational functions to facilitate the significant anticipated expansion of the company's business with the expected legalization of adult use cannabis in Canada by July 2018. Sandy Pratt, CPA, CA, has resigned as Chief Financial Officer to pursue other opportunities.

Mr. Hill brings over 20 years of accounting, finance, and senior leadership experience to Emerald as a seasoned manager of private and publicly traded technology and financial services businesses in Canada, USA, and Asia. Prior to joining Emerald, Mr. Hill was the Chief Financial Officer of Tokyo-based Minkabu. Before that, he held financial leadership positions at Haywood Securities in Vancouver and Vignette Corp.

and Trilogy Software in Austin, Texas. Ms. Evans has almost 20 years of management experience in the accounting, finance and treasury functions of publicly listed and highly regulated private companies. Prior to Emerald, she held various roles including Director, Regulatory Compliance and Director, Finance at AscendantFX Capital Inc. and VP, Financial Operations at Partners Real Estate Investment Trust.